Prostate Cancer Trial, Recruiting (NCT05306600)

Prostate Cancer Trial, Recruiting NCT05306600 Sponsor: Hospital Moinhos de Vento Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05306600 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with breast cancer (Arm 1):

You are a woman aged 18 or older
You are a Brazilian national
Your breast cancer diagnosis has been confirmed by a tissue biopsy and reviewed at Hospital Moinhos de Vento, and your cancer is either HER2-positive (a specific protein type) or triple-negative (confirm with trial site for exact test results)
Your cancer is at a certain stage — Stage II or III for HER2-positive, or Stage I, II, or III for triple-negative
You are receiving (or plan to receive) a specific type of chemotherapy before surgery, depending on your cancer type (confirm with trial site for exact treatment regimens)
You are willing and able to sign a consent form before joining

For people with prostate cancer (Arm 2):

You are a man aged 18 or older
Your prostate cancer has been confirmed by a tissue biopsy
Your cancer is at Stage IV
You are willing and able to sign a consent form before joining

Who may not be able to join:

There is no preserved tissue sample from your tumor available for genetic testing
It is not possible to take a blood sample from you for genetic testing

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Daniela D Rosa, PhD, Hospital Moinhos de Vento

Phone: +555135378345

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05306600

Sponsor: Hospital Moinhos de Vento

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

Trial contact: +555135378345

More information: https://clinicaltrials.gov/study/NCT05306600

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For people with breast cancer (Arm 1):

You are a woman aged 18 or older
You are a Brazilian national
Your breast cancer diagnosis has been confirmed by a tissue biopsy and reviewed at Hospital Moinhos de Vento, and your cancer is either HER2-positive (a specific protein type) or triple-negative (confirm with trial site for exact test results)
Your cancer is at a certain stage — Stage II or III for HER2-positive, or Stage I, II, or III for triple-negative
You are receiving (or plan to receive) a specific type of chemotherapy before surgery, depending on your cancer type (confirm with trial site for exact treatment regimens)
You are willing and able to sign a consent form before joining

For people with prostate cancer (Arm 2):

You are a man aged 18 or older
Your prostate cancer has been confirmed by a tissue biopsy
Your cancer is at Stage IV
You are willing and able to sign a consent form before joining

Who may not be able to join:

There is no preserved tissue sample from your tumor available for genetic testing
It is not possible to take a blood sample from you for genetic testing

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Hospital Moinhos de Vento

Registry

ClinicalTrials.gov

Start date

9 November 2022

Est. completion

31 December 2026

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

To characterize complete somatic and germline exomes/genomes in a Brazilian population

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov